Back to CBST Stock Lookup

CBST Related Analyst Ratings

May 24, 2013 07:10 AM Janney Montgomery Scott Downgrades Cubist Pharmaceuticals (CBST) to Neutral

May 21, 2013 12:39 PM UPDATE: Cantor Fitzgerald Upgrades Cubist Pharmaceuticals (CBST) to Hold

May 3, 2013 06:45 AM UBS Starts Cubist Pharmaceuticals (CBST) at Buy

Apr 3, 2013 07:48 AM Cantor Fitzgerald Downgrades Cubist Pharmaceuticals (CBST) to Sell; Doesn't See Deal for Optimer (OPTR)

Mar 15, 2013 07:46 AM Credit Suisse Starts Cubist Pharmaceuticals (CBST) at Neutral

Feb 20, 2013 01:06 PM Goldman Sachs Conviction Buy Stocks With the Most Upside (PANW) (AAPL) (HAL) more...

Jan 31, 2013 09:18 AM Janney Montgomery Scott Starts Cubist Pharmaceuticals (CBST) at Buy

Jan 24, 2013 08:16 AM Cantor Fitzgerald Upgrades Cubist Pharmaceuticals (CBST) to Hold

Jan 4, 2013 06:59 AM Baird Starts Cubist Pharmaceuticals (CBST) at Neutral

Nov 9, 2012 10:54 AM Mizuho Securities Starts Cubist Pharmaceuticals (CBST) at Neutral

Oct 25, 2012 07:52 AM Cantor Fitzgerald Starts Cubist Pharmaceuticals (CBST) at Sell, Sees Slowing Revenue Trajectory

Oct 19, 2012 09:53 AM Jefferies Raises Price Target on Cubist (CBST) to $55

Oct 17, 2012 08:42 AM Oppenheimer Raises Target on Cubist Pharmaceuticals (CBST) On Advancing Pipeline, Cubicin Growth Trajectory

Oct 4, 2012 08:26 AM Morgan Stanley Starts Cubist Pharmaceuticals (CBST) at Overweight

Sep 10, 2012 02:02 PM Wedbush Starts Durata Therapeutics (DRTX) at Outperform; Safety, Potency, Convenience Underpin Positive Outlook of Dalbavancin

Aug 8, 2012 08:48 AM Goldman Sachs Starts Cubist Pharmaceuticals (CBST) at Conviction Buy, Sees 24% Upside

Aug 1, 2012 08:11 AM SunTrust Robinson Humphrey Starts Cubist Pharmaceuticals (CBST) at Neutral

Jul 30, 2012 10:15 AM Needham & Company Downgrades Progenics Pharmaceuticals (PGNX) to Hold; Concerns on Lack of Clarity with Relistor

Jul 20, 2012 08:06 AM Caris & Co. Downgrades Cubist Pharmaceuticals (CBST) to Above Average

Jul 20, 2012 08:02 AM Jefferies Maintains a 'Buy' on Cubist Pharmaceuticals (CBST); Solid 2Q Cubicin Sales

Jul 20, 2012 07:54 AM Needham & Company Raises Estimates on Cubist Pharmaceuticals (CBST); Modestly Above Expectations

Jul 18, 2012 10:50 AM Needham & Company Q2 Preview on Cubist Pharmaceuticals (CBST); Cubicin Sales Estimate is $195M

Jun 12, 2012 09:10 AM Oppenheimer Maintains an 'Outperform' on Cubist Pharmaceuticals (CBST); Analyst Day Highlights

Jun 12, 2012 07:47 AM Needham & Company Maintains a 'Hold' on Cubist Pharmaceuticals (CBST); Review of Investor Day

May 11, 2012 08:18 AM Needham & Company Reiterates a 'Buy' on Optimer Pharmaceuticals (OPTR); Dificid Hits Sales Goal under Cubist Collaboration

Apr 19, 2012 07:36 AM Needham & Company maintains a 'Hold' on Cubist Pharmaceuticals (CBST); Cubicin Sales Beat; Awaiting Progression

Apr 4, 2012 11:05 AM Oppenheimer Raises PT and Estimates on Cubist Pharmaceuticals (CBST); Guidance Likely Conservative

Apr 4, 2012 07:58 AM Brean Murray Carret & Co. Starts Cubist Pharmaceuticals (CBST) at Hold; Waiting Until Next Growth Driver

Mar 23, 2012 08:46 AM ThinkEquity Starts Cubist Pharmaceuticals (CBST) at Buy

Mar 12, 2012 12:59 PM Baird Maintains an 'Outperform' on Optimer Pharmaceuticals (OPTR); Dificid Survey Suggests Good Growth Opportunity

Jan 20, 2012 10:47 AM Needham & Company Maintains a 'Hold' on Cubist Pharmaceuticals (CBST); 4Q11 Review. U.S. Cubicin Sales Guidance for 2012 In-line with Our Expectations

Jan 20, 2012 08:19 AM Jefferies Ups Price Target on Cubist Pharmaceuticals (CBST) Following FY12 Rev Guidance

Dec 28, 2011 07:42 AM Short Interest Ticks Up in Large-Cap Biotech, Specifically Amgen (AMGN)

Dec 23, 2011 07:35 AM Needham & Company 2012 Biotech Preview

Oct 25, 2011 08:27 AM Canaccord Genuity Reiterates a 'Buy' on Tranzyme (TZYM); Double-edged Sword: Cubist Enters POI

Oct 24, 2011 01:07 PM Brean Murray Carret & Co. Downgrades Adolor (ADLR) to Hold, Believes Deal is Fairly Valued

Oct 20, 2011 03:44 PM Wedbush Raises Price Target on Cubist Pharmaceuticals (CBST) Follwoing New Model Outlook

Oct 20, 2011 07:46 AM Baird Maintains an 'Outperform' on Cubist Pharmaceuticals (CBST); Q3-11: Sizable Beat and Raise

Oct 20, 2011 07:28 AM Needham & Company Reiterates a 'Buy' on Cubist Pharmaceuticals (CBST); 3Q11 U.S. Cubicin Sales Well Above Expectations

Sep 29, 2011 01:15 PM Needham & Company Reiterates 'Buy' on Optimer Pharmaceuticals (OPTR); Collaborator/Competitor Cubist Confirms Plans to Bring CB-315 into Phase 3

Sep 22, 2011 02:13 PM Needham & Company Maintains a 'Buy' on Cubist Pharmaceuticals (CBST); Favorably Inclined Towards the Stock

Jul 15, 2011 07:52 AM Needham & Company Reiterates a 'Buy' on Cubist Pharmaceuticals (CBST); 2Q11 Cubicin Sales Slightly Above Expectations and Guidance Raised for the Year

Jun 16, 2011 07:12 AM Cubist (CBST) Releases Positive Data on Two Phase 2 Studies of its Antibiotic Pipeline Candidates

Jun 2, 2011 09:52 AM Jefferies Bullish on Cubist's (CBST) CXA-201; Raises PT to $44

May 27, 2011 07:41 AM Global Hunter Securities Starts Cubist Pharmaceuticals (CBST) at Neutral; Solid Execution vs. Long-Term Pressures

Apr 20, 2011 07:19 AM Oppenheimer Upgrades Cubist Pharmaceuticals (CBST) to Outperform

Apr 15, 2011 08:36 AM Chardan Capital Downgrades Cubist Pharmaceuticals (CBST) to Neutral

Apr 15, 2011 08:07 AM Needham & Company Reiterates a 'Buy' on Cubist Pharmaceuticals (CBST); U.S. and International Cubicin Sales Beat Expectations

Apr 5, 2011 09:23 AM Lazard Capital Upgrades Cubist Pharmaceuticals (CBST) to Buy

Apr 5, 2011 09:10 AM Needham & Company Reiterates a 'Buy' on Cubist Pharmaceuticals (CBST); Teva and Cubist Settle Cubicin Litigation

Back to CBST Stock Lookup